Coagulation system factors

Coagulation system factors are a group of plasma proteins, primarily serine proteases and cofactors, that interact in a complex biochemical cascade to achieve hemostasis (StatPearls, NBK482253). This system is divided into the intrinsic, extrinsic, and common pathways, ultimately leading to the conversion of soluble fibrinogen into an insoluble fibrin mesh that stabilizes blood clots (NIH, NHLBI). Dysregulation of these factors can lead to either pathological thrombosis, such as deep vein thrombosis or stroke, or severe bleeding disorders like Hemophilia A and B (Merck Manuals). Pharmacological intervention often involves anticoagulants that inhibit specific factors like Thrombin (Factor IIa) or Factor Xa to prevent clot formation (PubMed, PMID: 30033778). Conversely, replacement therapies and antifibrinolytics are used to manage factor deficiencies or excessive bleeding. Understanding the balance of these factors is critical for managing cardiovascular health and surgical outcomes.

Other names

Blood clotting factorsClotting factorsHemostatic factorsCoagulation cascade proteins

Drugs targeting these factors typically act by inhibiting specific serine proteases (e.g., Factor Xa or Thrombin), antagonizing the recycling of Vitamin K required for factor synthesis, or replacing deficient factors in genetic disorders.